glp 1 drugs and hashimoto's GLP-1: what thyroid patients need to know before starting GLP-1 for Weight Loss and
Description
LEADER Steering Committee on behalf of the LEADER Trial Investigators
Remember, Wegovy has no hidden fees and does not require insurance, making it accessible for many
While all state Medicaid programs include GLP-1s prescribed for Type 2 diabetes, only 36 states cover at least one of the FDA-approved GLP-1s for obesity (Wegovy, Zepbound, or Saxenda)
After stopping tirzepatide, patients typically regain about two-thirds of lost weight within a year
These predispositions do not determine medication efficacy but may help contextualize variation in weight loss response across individuals
